4//SEC Filing
CHRISTOPHER RICHARD 4
Accession 0001348362-25-000011
CIK 0001348362other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:47 PM ET
Size
7.5 KB
Accession
0001348362-25-000011
Insider Transaction Report
Form 4
CHRISTOPHER RICHARD
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2025-05-15+150,000→ 350,000 totalExercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (150,000 underlying)
Holdings
- 50,000
common shares
- 200,000
Stock Options
Exercise: $3.92From: 2025-02-28Exp: 2029-08-31→ Common Shares (200,000 underlying)
Footnotes (1)
- [F1]50,000 options were exercisable on Feb. 28, 2025, an additional 6,818 options are exercisable every month thereafter until November 30, 2026 whereby the balance of 6,822 options will be exercisable on December 31, 2026
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001271244
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:47 PM ET
- Size
- 7.5 KB